피루브산 탈수소효소 키네이스 3
더 읽을거리

Sugden MC, Holness MJ (Jul 2002). “Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia”. 《Current Drug Targets. Immune, Endocrine and Metabolic Disorders》 2 (2): 151–65. doi:10.2174/1568008023340785. PMID 12476789.
Sugden MC, Holness MJ (May 2003). “Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs” (PDF). 《American Journal of Physiology. Endocrinology and Metabolism》 284 (5): E855–62. doi:10.1152/ajpendo.00526.2002. PMID 12676647. S2CID 12494500. 2019년 3월 8일에 원본 문서 (PDF)에서 보존된 문서.
Baker JC, Yan X, Peng T, Kasten S, Roche TE (May 2000). “Marked differences between two isoforms of human pyruvate dehydrogenase kinase”. 《The Journal of Biological Chemistry》 275 (21): 15773–81. doi:10.1074/jbc.M909488199. PMID 10748134.
Kolobova E, Tuganova A, Boulatnikov I, Popov KM (Aug 2001). “Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites”. 《The Biochemical Journal》 358 (Pt 1): 69–77. doi:10.1042/0264-6021:3580069. PMC 1222033. PMID 11485553.
Korotchkina LG, Patel MS (Oct 2001). “Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase”. 《The Journal of Biological Chemistry》 276 (40): 37223–9. doi:10.1074/jbc.M103069200. PMID 11486000.
Tuganova A, Boulatnikov I, Popov KM (Aug 2002). “Interaction between the individual isoenzymes of pyruvate dehydrogenase kinase and the inner lipoyl-bearing domain of transacetylase component of pyruvate dehydrogenase complex”. 《The Biochemical Journal》 366 (Pt 1): 129–36. doi:10.1042/BJ20020301. PMC 1222743. PMID 11978179.
Spriet LL, Tunstall RJ, Watt MJ, Mehan KA, Hargreaves M, Cameron-Smith D (Jun 2004). “Pyruvate dehydrogenase activation and kinase expression in human skeletal muscle during fasting” (PDF). 《Journal of Applied Physiology》 96 (6): 2082–2087. doi:10.1152/japplphysiol.01318.2003. PMID 14966024. S2CID 13601849. 2019년 2월 25일에 원본 문서 (PDF)에서 보존된 문서.
Blackshaw S, Harpavat S, Trimarchi J, Cai L, Huang H, Kuo WP, Weber G, Lee K, Fraioli RE, Cho SH, Yung R, Asch E, Ohno-Machado L, Wong WH, Cepko CL (Sep 2004). “Genomic analysis of mouse retinal development”. 《PLOS Biology》 2 (9): E247. doi:10.1371/journal.pbio.0020247. PMC 439783. PMID 15226823.
Kato M, Chuang JL, Tso SC, Wynn RM, Chuang DT (May 2005). “Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex”. 《The EMBO Journal》 24 (10): 1763–74. doi:10.1038/sj.emboj.7600663. PMC 1142596. PMID 15861126.
Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, Smolyar A, Bosak S, Sequerra R, Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M (Oct 2005). “Towards a proteome-scale map of the human protein-protein interaction network”. 《Nature》 437 (7062): 1173–8. Bibcode:2005Natur.437.1173R. doi:10.1038/nature04209. PMID 16189514. S2CID 4427026.
Tso SC, Kato M, Chuang JL, Chuang DT (Sep 2006). “Structural determinants for cross-talk between pyruvate dehydrogenase kinase 3 and lipoyl domain 2 of the human pyruvate dehydrogenase complex”. 《The Journal of Biological Chemistry》 281 (37): 27197–204. doi:10.1074/jbc.M604339200. PMID 16849321.
Devedjiev Y, Steussy CN, Vassylyev DG (Jul 2007). “Crystal structure of an asymmetric complex of pyruvate dehydrogenase kinase 3 with lipoyl domain 2 and its biological implications”. 《Journal of Molecular Biology》 370 (3): 407–16. doi:10.1016/j.jmb.2007.04.083. PMC 1994203. PMID 17532006.
Degenhardt T, Saramäki A, Malinen M, Rieck M, Väisänen S, Huotari A, Herzig KH, Müller R, Carlberg C (Sep 2007). “Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta”. 《Journal of Molecular Biology》 372 (2): 341–55. doi:10.1016/j.jmb.2007.06.091. PMID 17669420.
Kato M, Li J, Chuang JL, Chuang DT (Aug 2007). “Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol”. 《Structure》 15 (8): 992–1004. doi:10.1016/j.str.2007.07.001. PMC 2871385. PMID 17683942.
| v t e효소 |
| --- | --- |
활성:  활성 부위  결합 부위  촉매 삼잔기  산소 음이온 구멍  효소 다중기능성  확산 지배 효소  조효소  보조 인자  효소 촉매작용 
조절:  다른 자리 입체성 조절  협동작용  효소 저해제  효소 활성화제  효소 유도제 
분류:  EC 번호  효소 슈퍼패밀리  효소 패밀리  효소의 목록 (영어) 
반응속도론:  효소 반응속도론  미카엘리스-멘텐 반응속도론  라인위버-버크 플롯  이디-호프스티 다이어그램  헤인즈-울프 플롯 
종류:  EC1 산화 환원 효소 (목록)  EC2 전달 효소 (목록)  EC3 가수 분해 효소 (목록)  EC4 분해 효소 (목록)  EC5 이성질화 효소 (목록)  EC6 연결 효소 (목록)  EC7 자리옮김효소 (목록) 
| --- | --- |
: 생물학 포털